ARCHIVES

Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says.

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

Bennett Of NYU Heads NCI Director Search Committee

March 11, 1977

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980